News

A significantly larger portion of patients in the telitacicept 160 mg achieved SR14 response compared to the placebo group.

An analysis of more than 17,000 Veterans suggests early initiation of TNF inhibitor therapy in patients with ankylosing spondylitis was associated with an increased risk of incident cardiovascular disease and major adverse cardiovascular events.

Individuals who were socially isolated at time of fracture had significantly worse function, ability to participate in social roles, and depression time of fracture.

Anti-osteoporotic treatment resulted in increased BMD to a greater extent in patients treated with less than 5 mg per day of prednisone.

The results show improvements in RAPID3, pain, fatigue, and morning stiffness at weeks 8 and 12 among patients treated with upadacitinib.

Cuoghi Camille Edens, MD, discusses her upcoming ACR presentation, “Fertility and the Use of Assisted Reproductive Technologies: Perceptions, Thoughts and Experiences of Men and Women with Rheumatic Disease.”

Patients with ankylosing spondylitis generally had more favorable outcomes compared to those with psoriasis or psoriatic arthritis.

Although patients with autoimmune diseases are more likely to develop severe vaccine-preventable infections, vaccine uptake remains relatively low in this patient population.

In data presented during ACR, investigators find peresolimab could be an effective treatment for adult patients with rheumatoid arthritis.

EULAR guidelines suggest that non-pharmacological therapies should be prioritized over treatment with medication.

Investigators believe it is important to understand the patient's perspective regarding vaccine concerns and combining that perspective with stakeholders to prioritize topics for future research.

The association between type of body composition and fibromyalgia was evaluated using 43 women with clinically diagnosed fibromyalgia.

Previous studies have suggested a connection between rheumatic diseases, which often affect women in their reproductive years, and adverse pregnancy outcomes, such as pre-eclampsia.

The importance of patient-reported outcome measures (PROMs) for assessing the impact of diseases on patients and their response to treatment continues to grow. Test your knowledge of the role of the Rheumatoid Arthritis Impact of Disease (RAID) score in this quiz.

Abdul Abdellatif, MD, FASN, explains the results of the MIRROR RCT trial, in which the renal function of patients with gout receiving pegloticase plus methotrexate co-therapy was evaluated.

Bahar Moghaddam, MD, discusses the impact of arthritis worldwide, recent drug approvals, and the importance of early diagnosis and management of rheumatic diseases.

In this episode of the Overdrive podcast, Dr. McMahan sits down to discuss the upcoming ACR 22 Convergence meeting and what attendees might be able to expect from the perspective of an ACR Annual Meeting Planning Committee member.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending November 5, 2022.

While approximately 1 in 5 patients with RA went undiagnosed during the early stage of the COVID-19 pandemic, time to first rheumatology assessment and DMARD prescription were not impacted.

A significantly higher number of patients receiving voclosporin achieved good renal outcome when compared with placebo.

An analysis of data from the Cancer Prevention Study-II suggests cancer survivors had a more than doubling in risk of frailty-related bone fractures than their counterparts without cancer.

“Most thyroid diseases and rheumatoid arthritis are chronic diseases, and unfortunately, early signs of thyroid dysfunction are not specific and are often overshadowed by clinical manifestations of other diseases."

Investigators aimed to assess self-reported changes in physical activity during the COVID-19 pandemic.

Investigators note that healthcare approaches may benefit from including patient-reported experiences of living with and being treated for fibromyalgia.

"It may be important to identify genetic variants from a gout genome-wide association study (GWAS) rather than serum urate GWAS, in case these variants have an effect on gout independent of their effect on serum urate.”

The PRERA trial was the first real-world, non-interventional study to analyze radiographic progression in patients with RA or PsA treated with etanercept.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 29, 2022.

Investigators concluded febuxostat should still be used cautiously for patients with gout and cardiovascular diseases due to inconclusive results.

"Infections are one of the key determinants of early morbidity and mortality of patients with SLE, strongly linked to disease activity and immunosuppression."